Innovotech

Innovotech Rule of 40

The Rule of 40 of Innovotech (IOT.V) as of Nov 20, 2026 is 109.33 %. In the previous year, Rule of 40 was 87.75 % — a change of 24.59% (higher).

Rule of 40

109.33 %

YoY

24.59%

Last updated:

Rule of 40 of Innovotech is 2025 109.33 % . Rule of 40 of Innovotech was 2024 87.75 % . It decreases by 24.59% higher compared to the previous year.

The Innovotech Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2018
-31.86 CAD
Jan 1, 2019
14.93 CAD
Jan 1, 2020
29.33 CAD
Jan 1, 2021
42.25 CAD
Jan 1, 2022
-36.50 CAD
Jan 1, 2023
-27.06 CAD
Jan 1, 2024
87.75 CAD
Jan 1, 2025
109.33 CAD
The Innovotech Rule of 40 history
YEARRule of 40YoY
109.33 %+24.59%
87.75 %-424.32%
-27.06 %-25.87%
-36.50 %-186.39%
42.25 %+44.06%
29.33 %+96.47%
14.93 %-146.86%
-31.86 %-1,602.51%
2.12 %-95.81%
50.64 %-210.36%
-45.88 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Innovotech Stock analysis

What does Innovotech do? Innovotech Inc. generates revenue through the sale of proprietary assay kits, including MBEC Assay Kits, Order Biofilm Assays, and Coated MBEC Assay Lids, which are used in microbial biofilm research. The company also provides contract research services such as Antimicrobial Contract Research, Antimicrobial and Anti-Biofilm Agents testing (MIC and MBEC), and Customized Antimicrobial Testing (BEST Assay Testing and Implanted Medical Device Testing). Its antimicrobial silver products, AgreGuard-1 Silver Antimicrobial for Crop Protection and InnovoSIL Antimicrobial Silver Products, are sold to customers in agricultural and medical sectors. The firm targets research institutions, agricultural producers, and medical device manufacturers seeking biofilm and antimicrobial testing solutions. Innovotech's intellectual property portfolio supports its contract research services, which include testing for antimicrobial agents and materials under standards like TM100, ISO 22196, and USP 51. The company’s Biofilm Publications and SEM Library serve as additional resources for clients engaged in biofilm research. Its product offerings are tailored to sectors requiring microbial biofilm analysis, such as crop protection and medical device development, with AgreGuard-1 and InnovoSIL products specifically addressing antimicrobial needs in agriculture and medical applications. The company monetizes its proprietary technology through direct sales of assay kits and antimicrobial silver products, while contract research services provide recurring revenue streams. Clients include research organizations conducting biofilm studies, agricultural businesses using AgreGuard-1 for crop protection, and medical device manufacturers utilizing InnovoSIL for antimicrobial properties. Innovotech’s focus on specialized testing methodologies and branded products ensures consistent demand from niche markets requiring precise biofilm and antimicrobial evaluation. Innovotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Innovotech stock

Rule of 40 of Innovotech is 109.33 % in 2025.

On Eulerpool you can find the complete historical development of Rule of 40 Innovotech since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Innovotech

All Key Metrics — Innovotech